Region: Netherlands

Dutch enforcer blocks major media tie-up

RTL has called off its proposed acquisition of Talpa Network after the Dutch antitrust authority rejected proposed remedies for failing to prevent anticipated price rises for television advertisers and distributors.

30 January 2023

Dutch enforcer probes drugmakers over excessive pricing and tying

The Dutch competition authority has launched a preliminary investigation to determine if three pharmaceutical companies are tying their services and charging excessive prices to both healthcare and insurance providers.

25 January 2023

Dutch enforcer tests remedies in high-profile media tie-up

Broadcasters RTL and Talpa Network have offered remedies to the Dutch antitrust authority after it warned their planned merger could increase prices and reduce quality and innovation.

12 January 2023

Maverick recruits from Allen & Overy

Cyriel Ruers has joined Maverick Advocaten as a partner in Amsterdam after almost a decade with Allen & Overy’s Dutch antitrust group.

09 January 2023

Netherlands: SEPs and FRAND – litigation, policy and latest developments

Featured in SEP/FRAND Hub

02 December 2022

Consumer association and claims foundation left empty-handed as cartel damages claims ruled inadmissible by Dutch district court

Featured in Class actions hub

Judges have backed Philips’ argument that claims by a consumer association and claims foundation following the EU cathode-ray cartel decision lack standing, holding that declaratory judgments would provide no additional value.

02 December 2022

Netherlands: Class actions – litigation, policy and latest developments

Featured in Class actions hub

02 December 2022

Dutch court to ask ECJ if parity clauses are ancillary restraints

A Dutch court overseeing Booking.com’s dispute with dozens of hotels said it plans to ask the European Court of Justice if wide and narrow parity clauses can be exempt from EU competition rules, as well as how to define the relevant market for online travel agencies.

30 November 2022

Biosimilar Competition: an Economist’s Perspective

Featured in The Guide to Life Sciences - First Edition

The competition provided by biosimilars can offer substantial savings for health systems, but concerns remain regarding its effects on competitive dynamics and implications for businesses following recent antitrust investigations in Europe.

21 October 2022

Netherlands: Price and Supply Security Remain Regulator’s Top Priorities

Featured in The Guide to Life Sciences - First Edition

Providing consumers with access to medicines at a reasonable price is the key driverof regulatory and legislative change in the life sciences sector in the Netherlands.

21 October 2022

Unlock unlimited access to all Global Competition Review content